SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-067428
Filing Date
2023-08-15
Accepted
2023-08-15 06:23:10
Documents
86
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea183360-6k_mainzbio.htm   iXBRL 6-K 17237
2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea183360ex99-1_mainzbio.htm EX-99.1 84719
3 UNAUDITED FINANCIAL STATEMENTS OF MAINZ BIOMED N.V. AS OF AND FOR THE THREE AND ea183360ex99-2_mainzbio.htm   iXBRL EX-99.2 576286
4 PRESS RELEASE DATED AUGUST 15, 2023 ea183360ex99-3_mainzbio.htm EX-99.3 78929
5 GRAPHIC ex99-3_001.jpg GRAPHIC 3425
  Complete submission text file 0001213900-23-067428.txt   4717668

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mynz-20230630.xsd EX-101.SCH 102911
7 XBRL CALCULATION FILE mynz-20230630_cal.xml EX-101.CAL 41056
8 XBRL DEFINITION FILE mynz-20230630_def.xml EX-101.DEF 243521
9 XBRL LABEL FILE mynz-20230630_lab.xml EX-101.LAB 533945
10 XBRL PRESENTATION FILE mynz-20230630_pre.xml EX-101.PRE 260122
80 EXTRACTED XBRL INSTANCE DOCUMENT ea183360-6k_mainzbio_htm.xml XML 554743
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 231173155
SIC: 2834 Pharmaceutical Preparations